MSTN and Hyperglycemia: MSTN signaling also affects glucose metabolism, with Mstn−/− mice able to maintain normal or lower fasting glucose levels despite having lower insulin levels (11, 101) and loss of MSTN capable of partially suppressing the development of hyperglycemia and enhancing glucose clearance in genetically obese mice (101).